No tariffs on anti-cancer medicines to China from May
By Hu Yongqi |
chinadaily.com.cn |
Updated: 2018-04-12 20:41
Share
Share - WeChat
Starting May 1, China will levy no tariffs on imports of anti-cancer medicines, the State Council said on Thursday.
The State Council released this news at its executive meeting on April 12, chaired by Premier Li Keqiang.
The meeting decided to develop the Internet plus Medical and Healthcare strategy to let Chinese citizens get better access to medical treatments and improve their health.
Premier Li Keqiang visited Shanghai Roche Pharmaceuticals, which focuses on anti-cancer medicines, on Tuesday. He said: "We welcome foreign companies to invest in China and will further open up. Opening-up is a policy that boosts national development and benefits the people."
Related Stories
- Chinese biotech firm Beroni partners Aussie university to trial anti-cancer molecule
- Changes to daily life from 'two sessions' policies
- Li says further opening-up of economy to benefit everyone
- 10 springtime foods to indulge your palate
- Roche receives FDA approval for complementary PD-L1 (SP263) biomarker test
- Courts crackdown on online misconduct, emerging business violations
- China's annual IP conference kicks off in Beijing
- CNS Fujian, China's largest aircraft carrier, conducts training operations in South China Sea
- China identifies new critical mineral deposits
- Remains of fallen heroes returned to China
- TBEA accelerates smart manufacturing in Xinjiang
